Doing pretty good today. I think this has a lot more in the tank!
Recent BGLC News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/14/2026 09:20:27 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:25:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/17/2026 06:30:11 PM
- BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform • GlobeNewswire Inc. • 03/11/2026 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 01:35:38 PM
- BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman • GlobeNewswire Inc. • 02/23/2026 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/03/2026 09:10:29 PM
- BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN’s Multi-Billion Dollar Market • GlobeNewswire Inc. • 01/28/2026 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/30/2025 06:30:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2025 10:20:34 PM
- BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™ • GlobeNewswire Inc. • 12/03/2025 01:45:00 PM
- BioNexus Gene Lab Shares Jump After Securing $500 Million Equity Facility • IH Market News • 12/02/2025 03:34:38 PM
- BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization • GlobeNewswire Inc. • 12/02/2025 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/02/2025 01:00:50 PM
- BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene • GlobeNewswire Inc. • 12/01/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 10:21:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 01:00:39 PM
- BioNexus Gene Lab Shares Surge on Strategic MRD Testing Partnership • IH Market News • 11/12/2025 03:24:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 01:32:04 PM
- BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization • GlobeNewswire Inc. • 11/12/2025 01:00:00 PM
- BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth Opportunities • GlobeNewswire Inc. • 11/10/2025 01:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/07/2025 09:32:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2025 12:00:49 PM
- BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc. • GlobeNewswire Inc. • 10/20/2025 12:00:09 PM

